Skip to main content

Peer Review reports

From: FKBPL and its peptide derivatives inhibit endocrine therapy resistant cancer stem cells and breast cancer metastasis by downregulating DLL4 and Notch4

Original Submission
17 Dec 2018 Submitted Original manuscript
3 Jan 2019 Author responded Author comments - Lana McClements
Resubmission - Version 2
3 Jan 2019 Submitted Manuscript version 2
14 Feb 2019 Reviewed Reviewer Report - Jean-Philippe Brosseau
24 Feb 2019 Reviewed Reviewer Report - Min Zheng
26 Feb 2019 Author responded Author comments - Lana McClements
Resubmission - Version 3
26 Feb 2019 Submitted Manuscript version 3
13 Mar 2019 Author responded Author comments - Lana McClements
Resubmission - Version 4
13 Mar 2019 Submitted Manuscript version 4
Publishing
20 Mar 2019 Editorially accepted
11 Apr 2019 Article published 10.1186/s12885-019-5500-0

You can find further information about peer review here.

Back to article page